Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Single-center, Open-label, Single-dose Ascending Phase I Clinical Study Evaluating the Safety, Tolerability, and Pharmacokinetic Profile of HHT201 (Donepezil Dihydroxynaphthalate for Injection) in Healthy Subjects

Authors not listed

Shanghai Synergy Pharmaceutical Sciences Co., Ltd. · 2024

Abstract

The objective of this study is to evaluate the safety and pharmacokinetic profiles of HHT201 in healthy subjects.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-13 MST

Cite this

APA
Anonymous. (2024). A Single-center, Open-label, Single-dose Ascending Phase I Clinical Study Evaluating the Safety, Tolerability, and Pharmacokinetic Profile of HHT201 (Donepezil Dihydroxynaphthalate for Injection) in Healthy Subjects. <em>Shanghai Synergy Pharmaceutical Sciences Co., Ltd.</em>. https://clinicaltrials.gov/study/NCT06373094
Vancouver
Anonymous. A Single-center, Open-label, Single-dose Ascending Phase I Clinical Study Evaluating the Safety, Tolerability, and Pharmacokinetic Profile of HHT201 (Donepezil Dihydroxynaphthalate for Injection) in Healthy Subjects. Shanghai Synergy Pharmaceutical Sciences Co., Ltd.. 2024.
BibTeX
@misc{anon2024ASingl, title = {A Single-center, Open-label, Single-dose Ascending Phase I Clinical Study Evaluating the Safety, Tolerability, and Pharmacokinetic Profile of HHT201 (Donepezil Dihydroxynaphthalate for Injection) in Healthy Subjects}, author = {Anonymous}, journal = {Shanghai Synergy Pharmaceutical Sciences Co., Ltd.}, year = {2024}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings